Shehata, A.M.; Elbadawy, H.M.; Ibrahim, S.R.M.; Mohamed, G.A.; Elsaed, W.M.; Alhaddad, A.A.; Ahmed, N.; Abo-Haded, H.; El-Agamy, D.S.
Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-κB Crosstalk. Plants 2022, 11, 2441.
https://doi.org/10.3390/plants11182441
AMA Style
Shehata AM, Elbadawy HM, Ibrahim SRM, Mohamed GA, Elsaed WM, Alhaddad AA, Ahmed N, Abo-Haded H, El-Agamy DS.
Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-κB Crosstalk. Plants. 2022; 11(18):2441.
https://doi.org/10.3390/plants11182441
Chicago/Turabian Style
Shehata, Ahmed M., Hossein M. Elbadawy, Sabrin R. M. Ibrahim, Gamal A. Mohamed, Wael M. Elsaed, Aisha A. Alhaddad, Nishat Ahmed, Hany Abo-Haded, and Dina S. El-Agamy.
2022. "Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-κB Crosstalk" Plants 11, no. 18: 2441.
https://doi.org/10.3390/plants11182441
APA Style
Shehata, A. M., Elbadawy, H. M., Ibrahim, S. R. M., Mohamed, G. A., Elsaed, W. M., Alhaddad, A. A., Ahmed, N., Abo-Haded, H., & El-Agamy, D. S.
(2022). Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-κB Crosstalk. Plants, 11(18), 2441.
https://doi.org/10.3390/plants11182441
